Recap: Replimune Group Q4 Earnings
Portfolio Pulse from Benzinga Insights
Replimune Group (NASDAQ:REPL) reported Q4 earnings, missing estimates by 7.25% with an EPS of $-0.74 compared to the expected $-0.69. Revenue remained unchanged from the same period last year. Last quarter, the company beat EPS estimates by $0.06, followed by a 2.27% drop in share price.
May 18, 2023 | 2:25 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Replimune Group's Q4 earnings missed estimates by 7.25%, reporting an EPS of $-0.74. Last quarter, the company beat EPS estimates, followed by a 2.27% drop in share price.
Replimune Group missed Q4 earnings estimates, which could negatively impact the stock price in the short term. Last quarter, the company beat EPS estimates, but the share price still dropped by 2.27%. This suggests that investors may react negatively to the earnings miss, leading to a potential decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100